Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-089 in Children with ADHD
NCT00640419Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Mar 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pozanicline in attention deficit hyperactivity disorder (ADHD), sponsored by AbbVie Inc.. Started Mar 2008; status: completed.
02
Drugs
pozanicline
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00640419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640419.